Stocktoria
Biomea Fusion, Inc. BMEA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-04-16
Chart by TradingView
2/9
Piotroski F — financial health
-28.25
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$83.5M | -$144.1M | -$126.1M | -$83.6M | -$41.7M |
| Net income | -$61.8M | -$138.4M | -$117.3M | -$81.8M | -$41.6M |
| Operating cash flow | -$70.4M | -$119.9M | -$96.6M | -$62.4M | -$35.4M |
| Free cash flow | — | -$120.3M | -$100.0M | -$63.4M | -$38.6M |
| Total assets | $58.6M | $79.9M | $199.9M | $129.3M | $185.7M |
| Total liabilities | $29.0M | $28.4M | $30.7M | $20.8M | $6.9M |
| Shareholders' equity | $29.6M | $51.6M | $169.2M | $108.5M | $178.8M |
| Ratios | |||||
| Return on assets | -105.5% | -173.2% | -58.6% | -63.3% | -22.4% |
| Return on equity | -209.1% | -268.4% | -69.3% | -75.4% | -23.2% |
| Current ratio | 5.23 | 3.15 | 7.84 | 6.17 | 38.08 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 1,312,798 | $2.0M |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -28.25 (distress)
- Working capital / assets 0.802
- Retained earnings / assets -7.667
- EBIT / assets -1.426
- Equity / liabilities 1.018
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001840439 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.